Trial intelligence / Profile preview

Omeprazole for infant gastroesophageal reflux disease

IRCT201112135330N2Phase 2Completed

Sponsor
Tabriz University of Medical Sciences
Start
Aug 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, single-arm trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Tabriz University of Medical Sciences. Started Aug 2011; status: completed.

02

Drugs

omeprazole
03

Conditions

gastroesophageal reflux disease (GERD)

Beyond the preview

Go deeper on IRCT201112135330N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201112135330N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call